Furthermore, published studies have suggested that the release of inflammatory cytokines involving IL-1β, IL-6, and TNF-α participated in activating p38 MAPK and JNK signaling pathways in chronic lung diseases (Barnes et al., 2019). Here, IL1B is linked to chronic lung disease.